Istesso, the drug discovery biotech focused on immunometabolism founded in 2017, has raised £10M in funding.
© 2023 London TechWatch | All Rights Reserved | Proudly Made for London
© 2023 London TechWatch | All Rights Reserved | Proudly Made for London
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.